The Stockholm Stock Exchange concluded an earnings-heavy Wednesday in negative territory, tracking the performance of leading European bourses. Today's slate of results featured major banks SEB and Swedbank, alongside Volvo Cars and AstraZeneca.

At the close, the OMXS30 index was down 0.51 percent at 3,040.54. Adjusted for dividends, the OMXS30 fell 0.24 percent. Shares worth approximately SEK 24.4 billion changed hands on the Stockholm Stock Exchange.

Among the major industrial sectors, telecommunications led the gains with a 0.7 percent rise. At the other end of the spectrum, energy lagged behind, declining 1.7 percent.

Among the blue-chip stocks in the OMXS30 index, Epiroc A climbed 7.0 percent, while Ericsson B rose 1.8 percent. H&M B was the worst performer, dropping 3.0 percent, while EQT fell 2.1 percent.

Banking giant SEB reported operating profit that exceeded analyst expectations, while revenue and net interest income were in line with consensus. The bank is launching a new SEK 1.25 billion share buyback program. SEB shares edged up 0.2 percent. Peer Swedbank also posted a better-than-expected operating profit, with net interest income also beating consensus. Swedbank plans to sell Payex and reduce its workforce by approximately 550 positions. Swedbank shares increased 0.5 percent.

Pharmaceutical company AstraZeneca reported revenue and adjusted earnings per share in line with analyst expectations. The company reiterated its 2026 outlook. The stock fell 1.3 percent.

Automaker Volvo Cars posted an operating profit significantly higher than anticipated, while revenue met consensus. The stock fell 3.9 percent.

Mining and rock excavation equipment group Epiroc reported an adjusted operating profit of SEK 2,868 million, missing expectations. However, order intake was 10 percent stronger than forecast at SEK 18,340 million.

Vehicle manufacturer Traton delivered a mixed report, where adjusted operating profit beat expectations while revenue came in weaker than anticipated. Order intake in terms of units rose by 18 percent. The stock rose 0.6 percent.

Construction company Peab reported slightly lower revenue and a reduced operating loss for the first quarter of 2026 compared to the same period last year. The first quarter is typically seasonally weak for the company. The stock fell 5 percent.

Investment company Latour reported that its net asset value underperformed its benchmark index in the first quarter. Net asset value stood at SEK 206 per share as of April 28. The stock fell 3.2 percent.

Research company BioArctic announced that its partner Eisai reached global sales exceeding EUR 500 million for Leqembi during the fiscal year April 2025-March 2026. This triggers a milestone payment of EUR 20 million to BioArctic. The stock rose 2.7 percent.

Online pharmacy Apotea reported a solid increase in both revenue and operating profit for the first quarter compared to the same quarter last year. The stock was rewarded with a 12.8 percent gain.

Among other earnings winners, Bico climbed 10 percent and MTG advanced 9.8 percent. On the losing side following their reports were Momentum, which plunged 17 percent, and B3, which retreated 12.7 percent.